Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPI1 | P60174 | 2/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.33 |
| ▸ | PGK1 | P00558 | 1/20 | 0.33 |
| ▸ | PGK2 | P07205 | 1/20 | 0.33 |
| ▸ | FBP1 | P09467 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | PGD | P52209 | 2/20 | 0.31 |
| ▸ | MPI | P34949 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL3330065 | 1.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL10847788 | 1.00 | TPI1 (0.34) | TPI1LPAR3LPAR2LPAR1PGK1 | |
| SCHEMBL4670278 | 0.97 | — | — | |
| Potassium Ion SCHEMBL5807703 | 0.95 | TPI1 (0.34) | TPI1LPAR3LPAR2LPAR1PGK1 | |
| SCHEMBL6794240 | 0.95 | TPI1 (0.34) | TPI1LPAR3LPAR2LPAR1PGK1 | |
| Phosphoric Acid SCHEMBL7714297 | 0.95 | TPI1 (0.34) | TPI1LPAR3LPAR2LPAR1PGK1 | |
| Potassium Ion SCHEMBL5803916 | 0.84 | SLC34A1 (0.32) | — | |
| SCHEMBL4892596 | 0.83 | LPAR3 (0.35) | LPAR3LPAR2LPAR1FBP1FDPS | |
| Butylamine SCHEMBL9405028 | 0.78 | LPAR3 (0.44) | LPAR3LPAR2LPAR1FDPS | |
| SCHEMBL14118485 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023175210-A1 | CUSTOMISED IMPLANTS HAVING ANTIMICROBIAL ACTIVITY FOR PREVENTING AND TREATING BONE INFECTIONS | UNIVERSIDAD COMPLUTENSE DE MADRID (ES) | 2023-09-21 | — | — | WO | disclosed |
| CN-113024658-B | Method for purifying liraglutide | 翰宇药业（武汉）有限公司 | 2022-10-21 | — | — | CN | disclosed |
| EP-3433268-B1 | PURIFICATION OF GLUCAGON-LIKE PEPTIDE 1 ANALOGS | BACHEM HOLDING AG (CH) | 2021-07-28 | — | — | EP | disclosed |
| CN-113024658-A | Method for purifying liraglutide | 翰宇药业（武汉）有限公司 | 2021-06-25 | — | — | CN | disclosed |
| US-20200371069-A1 | PURIFICATION OF GLUCAGON-LIKE PEPTIDE 1 ANALOGS | BACHEM HOLDING AG (CH) | 2020-11-26 | — | — | US | disclosed |
| US-10690635-B2 | Purification of glucagon-like peptide 1 analogs | BACHEM HOLDING AG (CH) | 2020-06-23 | — | — | US | disclosed |
| US-20190113483-A1 | PURIFICATION OF GLUCAGON-LIKE PEPTIDE 1 ANALOGS | BACHEM HOLDING AG (CH) | 2019-04-18 | — | — | US | disclosed |
| CN-109311960-A | Method for purifying glucagon-like peptide 1 analogue | 巴切姆股份公司 | 2019-02-05 | — | — | CN | disclosed |
| EP-3433268-A1 | PURIFICATION OF GLUCAGON-LIKE PEPTIDE 1 ANALOGS | Bachem Holding AG (CH) | 2019-01-30 | — | — | EP | disclosed |
| WO-2017162653-A1 | PURIFICATION OF GLUCAGON-LIKE PEPTIDE 1 ANALOGS | BACHEM HOLDING AG (CH) | 2017-09-28 | — | — | WO | disclosed |
| US-20050027034-A1 | Anaesthetic bone cement | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2005-02-03 | — | — | US | disclosed |
| EP-0973558-B1 | ANAESTHETIC BONE CEMENT | UNIV KINGSTON (CA) | 2004-09-22 | — | — | EP | disclosed |
| US-6713527-B2 | BONE CEMENT CONTAINING UP TO ABOUT 5% BY WEIGHT OF A LOCAL ANAESTHETIC | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2004-03-30 | — | — | US | disclosed |
| US-20020137813-A1 | Anaesthetic bone cement | QUEEN'S UNIVERSITY AT KINGSTON. | 2002-09-26 | — | — | US | disclosed |
| EP-0973558-A1 | ANAESTHETIC BONE CEMENT | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2000-01-26 | — | — | EP | disclosed |
| WO-1998034653-A1 | ANAESTHETIC BONE CEMENT | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1998-08-13 | — | — | WO | disclosed |
| US-5206360-A | Bactericides | BRISTOL-MYERS SQUIBB COMPANY (US) | 1993-04-27 | — | — | US | disclosed |
| US-5169843-A | Bactericides | BRISTOL-MYERS SQUIBB COMPANY (US) | 1992-12-08 | — | — | US | disclosed |
| EP-0484030-A2 | Antibiotic C-3 cyclobutenedione substituted (1-carba)cephalosporin compounds, compositions, and methods of use thereof | Bristol-Myers Squibb Company (US) | 1992-05-06 | — | — | EP | disclosed |
| US-5106842-A | Bactericides | BRISTOL-MYERS SQUIBB CO. (US) | 1992-04-21 | — | — | US | disclosed |